Go Pro

Heartflow (NASDAQ:HTFL) Stock Rating Upgraded by Robert W. Baird

Heartflow logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Robert W. Baird upgraded Heartflow to “strong buy,” joining another strong-buy recommendation. Analysts’ overall consensus is “Moderate Buy,” with an average price target of $36.57.
  • Heartflow opened at $25.23, down 2.3%, with a $2.18 billion market capitalization. Its latest quarterly results beat EPS expectations, while revenue increased 41.3% year over year to $52.59 million.
  • Company insiders sold 115,805 shares worth approximately $3.55 million in the last quarter, while several institutional investors—including Vanguard and Franklin Resources—recently established positions.
  • Five stocks to consider instead of Heartflow.

Heartflow (NASDAQ:HTFL - Get Free Report) was upgraded by equities research analysts at Robert W. Baird to a "strong-buy" rating in a research note issued to investors on Friday,Zacks.com reports.

HTFL has been the subject of several other reports. Stifel Nicolaus set a $40.00 target price on Heartflow in a research note on Wednesday, July 15th. Piper Sandler reaffirmed an "overweight" rating on shares of Heartflow in a report on Thursday, June 11th. Weiss Ratings lowered Heartflow from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, July 8th. Wells Fargo & Company lifted their price objective on shares of Heartflow from $35.00 to $37.00 and gave the company an "overweight" rating in a research report on Friday, May 15th. Finally, Freedom Capital raised Heartflow to a "strong-buy" rating in a report on Tuesday, June 30th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $36.57.

Get Our Latest Report on HTFL

Heartflow Trading Down 2.3%

NASDAQ HTFL opened at $25.23 on Friday. Heartflow has a 12-month low of $20.13 and a 12-month high of $41.22. The company has a fifty day simple moving average of $29.02 and a two-hundred day simple moving average of $28.10. The stock has a market cap of $2.18 billion and a P/E ratio of -8.11.

Heartflow (NASDAQ:HTFL - Get Free Report) last posted its earnings results on Thursday, May 14th. The company reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.24) by $0.08. The business had revenue of $52.59 million for the quarter. The business's revenue was up 41.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Heartflow will post -0.82 earnings per share for the current year.

Insider Buying and Selling at Heartflow

In other news, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction on Monday, May 18th. The stock was sold at an average price of $28.34, for a total value of $261,266.46. Following the transaction, the insider owned 78,731 shares in the company, valued at approximately $2,231,236.54. This trade represents a 10.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 38,900 shares of the stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00. Following the completion of the sale, the chief executive officer directly owned 457,935 shares of the company's stock, valued at approximately $16,027,725. This trade represents a 7.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 115,805 shares of company stock worth $3,548,884 in the last quarter. Company insiders own 7.70% of the company's stock.

Institutional Investors Weigh In On Heartflow

Institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. purchased a new stake in Heartflow during the third quarter worth about $48,871,000. Legal & General Group Plc acquired a new position in shares of Heartflow in the third quarter worth $59,000. Franklin Resources Inc. acquired a new stake in shares of Heartflow in the third quarter valued at $10,829,000. UBS Group AG acquired a new position in Heartflow during the 3rd quarter worth $5,130,000. Finally, Sei Investments Co. purchased a new position in shares of Heartflow in the 3rd quarter valued at about $303,000.

About Heartflow

(Get Free Report)

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

Further Reading

Analyst Recommendations for Heartflow (NASDAQ:HTFL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Heartflow Right Now?

Before you consider Heartflow, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.

While Heartflow currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines